18F-MFBG PET/CT与18F-FDG PET/CT在转移性神经母细胞瘤图像中的比较
两名神经母细胞瘤患儿在肿瘤切除及术后化疗后参加临床试验,接受18F-MFBG与18F-FDG PET/CT检查。两次检查发现相似病灶但摄取模式不同:淋巴结和骨病灶18F-MFBG活性强而18F-FDG摄取不明显,骨髓18F-MFBG摄取显著强于18F-FDG。本文强调18F-MFBG PET/CT在检测神经母细胞瘤转移方面优于18F-FDG PET/CT。
要点
- 淋巴结和骨病灶18F-MFBG活性强,而18F-FDG摄取不明显。
- 骨髓18F-MFBG摄取显著强于18F-FDG。
- 本文强调18F-MFBG PET/CT检测神经母细胞瘤转移优于18F-FDG PET/CT。
核心结论
- 本文强调18F-MFBG PET/CT在检测神经母细胞瘤转移方面优于18F-FDG PET/CT。
研究设计与样本
- 两名神经母细胞瘤患儿在肿瘤切除及术后化疗后参加临床试验,接受18F-MFBG与18F-FDG PET/CT检查。
主要发现
- 两次检查发现相似病灶,但摄取模式不同。
- 淋巴结和骨病灶18F-MFBG活性强,而18F-FDG摄取不明显。
- 骨髓18F-MFBG摄取显著强于18F-FDG。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Two children with neuroblastoma underwent tumor resection and postoperative chemotherapy. After treatment, they participated in a clinical trial and received 18 F-MFBG and 18 F-FDG PET/CT examinations. Although similar lesions were found in the 2 examinations, the uptake pattern was different. The lymph nodes and bone lesions had intense 18 F-MFBG activity, whereas 18 F-FDG uptake was not very impressive. The uptake of bone marrow by 18 F-MFBG was significantly stronger than that by 18 F-FDG. This case emphasizes that 18 F-MFBG PET/CT is superior to 18 F-FDG PET/CT in detecting the metastases of neuroblastoma.
引用
- Zhang W, Liu L, Yuan G, et al. Comparison of 18 F-MFBG PET/CT and 18 F-FDG PET/CT Images of Metastatic Neuroblastoma. Clin Nucl Med. 2024. PMID: 38598743. doi:10.1097/RLU.0000000000005226
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。